Abstract
The data generated by DNA arrays are often described as the molecular “portrait” of a particular physiological / pathological sample. Although the emotional reactions could range from revulsion to adoration when viewing those portraits, as it might be when viewing some contemporary art, array technology has fundamentally changed the way researchers approach many biomedical questions. With its ability to monitor the expression level of tens of thousands genes simultaneously, microarray technology has been able to identify “markers” for complex diseases such as cancer. While massive amounts of work lie ahead to validate those marker genes, many researchers are turning their attentions to the low-density, focused arrays. When incorporated with current knowledge on specific biological pathways, these specially tailored macroarrays may be better fitted for purposes such as diagnosis, drug discovery and validation, and prognostic assessment of clinical treatments.
Keywords: microarray, macroarray, cdna array, focused array, pathway-specific array, apoptosis, cancer, biomarker
Current Pharmaceutical Biotechnology
Title: The Making of a Portrait - Bringing it into Focus
Volume: 4 Issue: 6
Author(s): Zeng X.
Affiliation:
Keywords: microarray, macroarray, cdna array, focused array, pathway-specific array, apoptosis, cancer, biomarker
Abstract: The data generated by DNA arrays are often described as the molecular “portrait” of a particular physiological / pathological sample. Although the emotional reactions could range from revulsion to adoration when viewing those portraits, as it might be when viewing some contemporary art, array technology has fundamentally changed the way researchers approach many biomedical questions. With its ability to monitor the expression level of tens of thousands genes simultaneously, microarray technology has been able to identify “markers” for complex diseases such as cancer. While massive amounts of work lie ahead to validate those marker genes, many researchers are turning their attentions to the low-density, focused arrays. When incorporated with current knowledge on specific biological pathways, these specially tailored macroarrays may be better fitted for purposes such as diagnosis, drug discovery and validation, and prognostic assessment of clinical treatments.
Export Options
About this article
Cite this article as:
X. Zeng, The Making of a Portrait - Bringing it into Focus, Current Pharmaceutical Biotechnology 2003; 4 (6) . https://dx.doi.org/10.2174/1389201033377364
DOI https://dx.doi.org/10.2174/1389201033377364 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Evolution and Pathogenesis of Oncoviruses Associated with Head and Neck Cancer: History and Current Concepts
Recent Patents on Biomarkers Editorial: The Real Impact of Target Therapy in Cancer Patients: Between Hope and Reality
Current Cancer Drug Targets Triazene Compounds in the Treatment of Acute Myeloid Leukemia: A Short Review and a Case Report
Current Medicinal Chemistry Metastatic Breast Cancer, Organotropism and Therapeutics: A Review
Current Cancer Drug Targets Past, Present and Future Therapeutics for Cerebellar Ataxias
Current Neuropharmacology Sulfur-based Mechanistic Probes for Enzyme-catalyzed Reactions
Current Medicinal Chemistry The Multifaceted Activities of Mammalian Defensins
Current Pharmaceutical Design Threes Company: Regulation of Cell Fate by Statins
Current Drug Targets - Cardiovascular & Hematological Disorders Tubulin-based Structure-affinity Relationships for Antimitotic Vinca Alkaloids
Anti-Cancer Agents in Medicinal Chemistry Epigenetic Mechanisms Underlying Diet-Sourced Compounds in the Prevention and Treatment of Gastrointestinal Cancer
Anti-Cancer Agents in Medicinal Chemistry subject Index To Volume 2
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Recent Patents and Patent Applications Relating to mTOR Pathway
Recent Patents on DNA & Gene Sequences Preliminary Experience with Yttrium-90-labelled Rituximab (Chimeric Anti CD-20 Antibody) in Patients with Relapsed and Refractory B Cell Non-Hodgkins Lymphoma
Current Radiopharmaceuticals Inhibitor at the Gates, Inhibitor in the Chamber: Allosteric and Competitive Inhibitors of the Proteasome as Prospective Drugs
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents An Advanced Computational Evaluation for the Most Biologically Active Enantiomers of Chiral Anti-Cancer Agents
Anti-Cancer Agents in Medicinal Chemistry Co-formulation of P-glycoprotein Substrate and Inhibitor in Nanocarriers: An Emerging Strategy for Cancer Chemotherapy
Current Cancer Drug Targets A Descriptive Analysis of Post-Chemotherapy Development of Interstitial Lung Disease Using Spontaneous Reporting Data in Japan
Current Drug Safety Editorial (Thematic Issue: Unlocking the Potential of Stem Cells in Cell Therapy, Drug Delivery and Drug Discovery)
Current Drug Delivery Tocilizumab Labeling with 99mTechnetium via HYNIC as a Molecular Diagnostic Agent for Multiple Myeloma
Anti-Cancer Agents in Medicinal Chemistry Supertargeted Chemistry: Identifying Relationships Between Molecular Structures and their Sub-Cellular Distribution
Current Topics in Medicinal Chemistry